2014

Healthcare Associated Infection (HAI) Control Markets: Disinfection, Area, Sterilization, Device Sterilization, Testing-C.diff, Testing-MRSA, Treatments

NEW YORK, June 16, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Healthcare Associated Infection (HAI) Control Markets: Disinfection, Area, Sterilization, Device Sterilization, Testing-C.diff, Testing-MRSA, Treatments

http://www.reportlinker.com/p02167908/Healthcare-Associated-Infection-HAI-Control-Markets-Disinfection-Area-Sterilization-Device-Sterilization-Testing-Cdiff-Testing-MRSA-Treatments.html

Infections from activities and procedures taking place within a healthcare facility have become a cause for great concern. These infection may occur in a postoperative wound or as a complication unrelated to the disease or condition. This report, Healthcare-Associated Infection (HAI) Control Markets: focuses on the market opportunities for companies that can assist hospitals and other healthcare facilities with important HAI mitigation tasks including: preventing, testing and treating infections in the healthcare environment.

The U.S. Centers for Disease Control and Prevention (CDC) estimates that around 1 in 20 or 5% of hospitalized patients will contract an HAI. Worldwide, the rate of nosocomial infections is between 3.5% and 12% of admissions in developed regions. This is driving the demand for products and services. The report focuses on three areas: Prevention, Testing and Treatment and will provide a market analysis for each of the important segments:

Disinfection
Wide-Area Sterilization
Device Sterilization
HAI Testing – C.diff
HAI Testing – MRSA
HAI Testing - Others
HAI Treatment –Antibiotic Products

For each larger segment (Prevention, Testing and Treatment) company market share is provided. For each larger segment (Prevention, Testing, Treatment) regional market share is provided for the following countries and regions: US, Europe, Eastern Europe, Japan, Canada, China, Mexico, Brazil, Africa, India, Rest of World.

Market analysis in this report considers primarily the epidemiological considerations and the size patient groups both in the United States and globally, where available. We have accumulated the most recent data available, understanding that virtually no organization does extensive studies on these applications on a regular basis. Many studies are highly localized and may only apply to a community, state or country (more often countries that are not a part of the majormarkets for nosocomial diagnostic and therapeutic products). In many instances, we have had to draw from broader epidemiologic data, that is, on data that reach outside of the hospital and primary care environment in order to construct a picture of the infection prevention, testing and treatment needs.

As part of the report's coverage, the following trends are discussed:

Nosocomial Infection Statistics
Affordable Care Act (ACA) Funding
Populations at Risk for Infection
Infection Risk Assessments by Hospital Department
Increased Hospital Length of Stay for HAIs
International Trends in Nursing Facilities
U.S. Government's National Plan to Prevent Healthcare
Government Funding for HAI Prevention Infrastructure Activities
Israel Reduction in HAIs
Arizona Prevention Study
Connecticut Funding for HAI Prevention and Reporting
Pennsylvania Study of HAI Admissions and Readmissions
Infections and Drug Resistance
Screening Trends
Trends in Partnerships and Alliances
Current Burden of HAI Statistics

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, reimbursement specialists, research scientists, business development managers and marketing managers.

ONE: EXECUTIVE SUMMARY
Overview

The Nosocomial Infection

Scope and Methodology
Total Size and Growth of the Market
Issues and Trends Affecting Market
Leading Competitors
TWO: INTRODUCTION AND INDUSTRY TRENDS
Overview

Introduction to Pathogens
Classification of Antibacterial Organisms
Patient Risk Factors
General Infection Statistics
Populations at Risk for Infection

Demographics of the World

Life Expectancy
Nosocomial Infection Statistics
Common Hospital (nosocomial) Infections
Description of Infections

Infection Risk Assessments by Hospital Department

Burn Units
Intensive Care Units
Emergency Departments
Hospital Length of Stay

Increased Hospital Length of Stay for HAIs

Extended Stay Environments

Home Healthcare Services
International Trends in Nursing Facilities

Economic Trends

Comparison Between Healthcare Spending and Real Health Outcomes
U.S. Government's National Plan to Prevent Healthcare Associated Infections (HAIs)47
Steering Committee
The American Recovery and Reinvestment Act of 2009
Affordable Care Act (ACA) Funding
Government Funding for HAI Prevention Infrastructure Activities
National Healthcare Safety Network
U.S. Statewide Standardized Infection Ratio

Reduction in Hospital Acquired Infections

Reduction in Infections in Israel
Burden of Hospital Acquired Infections
Healthcare Infection Surveillance Process

Case Studies

Arizona Prevention Study
Connecticut Funding for HAI Prevention and Reporting
Pennsylvania Study of HAI Admissions and Readmissions

Infections and Drug Resistance

Easing Approvals of Antibiotics
Causes of Drug Resistance

Antibiotic Abuse
Antibiotic Use in Agriculture

Drug Resistance in Select Populations

Children
The Elderly
Compromised Individuals

Measures for Reducing Resistance

Testing for the Selection of Anti-bacterial Therapy
Monitoring Therapy

Screening Hospitalized patients

Pharmaceutical Manufacturer and Marketer Trends

Trends in Partnerships and Alliances
Developers Trends

THREE: INFECTION PREVENTION
Overview

Methods of Transmission

Airborne
Contact
Droplet
Vehicle

High-Risk Facilities or Departments
Technology Overview

Potential Use of Copper for Reducing Infections
Wide Area Disinfection Methods
Software for Infection Detection and Control
Antiseptic-Coated Catheters
UV-C Reflective Coatings
Specialized Disinfection/Sterilization Systems

Sterilization vs. Disinfection

Sterilization
Disinfection

Equipment and Solutions
Heat/Steam Sterilization

Developments

Chemical Sterilization

Sterilants
Developments

Mid-Level Disinfectants

Suppliers

Radiation Sterilization

Developments

Sterilization and Disinfection Verification Systems

Market Overview

Healthcare Infection Prevention Market by Geographical Region
Competitive Analysis

FOUR: INFECTION TESTING
Overview

Drug-Resistance/Susceptibility Testing
Genotypic Methods

DNA Sequencing
Solid-phase Hybridization Techniques
Microarrays
Real-time Polymerase Chain Reaction Techniques
Phenotypic Methods
Phage-based Assays
Colorimetric Methods
The Nitrate Reductase Assay

Specific Serious Healthcare Infection Testing

Acinetobacter Baumannii
Clostridium Difficile

Developments

Hospital-Acquired Pneumonia
Pseudomonas Aeruginosa
Staphylococcus Aureus

Methicillin-resistant Staphylococcus Aureus (MRSA)
Vancomycin-Intermediate/Resistant Staphylococcus Aureus (VISA/VRSA)
Developments

Tuberculosis

Developments

Urinary Tract Infections
Vancomycin-resistant Enterococcus

Developments

Ventilator-Associated Pneumonia

New Developments
Market Overview
Total Market Size and Forecast

Healthcare Infection Testing Market by Geographical Region

Competitive Analysis
FIVE: INFECTION TREATMENT
Overview

Principles of Anti-bacterial Therapy

Infecting Organism
Antibiotic Sensitivity Testing
Site of Infection
Host Defenses and Organ Function
Antibiotic Pharmacokinetics
Monitoring Therapy

Classifications of Antibacterial Products

Carbapenems
Cephalosporins
Macrolides
Penicillins
Quinolones
Sulfonamides
Tetracyclines

Treatment Guidelines

Clostridium Difficile
Gastroenteritis
Hospital-Acquired Pneumonia
Ventilator-associated Pneumonia
Pseudomonas Aeruginosa
Staphylococcus Aureus
Stenotrophomonas maltophilia
Tuberculosis
Urinary Tract Infections

Leading Products
New Developments
Total Market Size and Forecast

Healthcare Infection Treatment Market by Geographical Region

Competitive Analysis
SIX: MARKET OPPORTUNITIES FOR HEALTHCARE INFECTION CONTROL
Market Considerations
Market Overview

Healthcare Infection Control Market by Geographical Region
Developed and Emerging Market Analysis

SEVEN: COMPANY PROFILES
Introduction
Advanced Sterilization Products

Company Performance

Becton, Dickinson and Company

Company Performance

Belimed

Company Performance

bioMerieux

Company Performance

Cantel

Company Performance

Cepheid

Company Performance

Getinge Group

Company Performance

Kimberly-Clark

Company Performance

Merck & Co

Company Performance

Nordion

Company Performance

Pfizer

Company Performance

Roche

Company Performance

Sakura Seiki
Steris

Company Performance

Tso3

Company Performance

APPENDIX: LIST OF MAJOR PROVIDERS

LIST OF EXHIBITS

ONE: EXECUTIVE SUMMARY
Table 1-1

Frequency of the Most Common Nosocomial Infections

Table 1-2

The World Market for Healthcare Infection Control 2008-2020

Figure 1-1

The World Market for Healthcare Infection Control 2008-2020

TWO: INTRODUCTION AND INDUSTRY TRENDS
Table 2-1

World Population at Risk for Serious Bacterial Infections, Secondary toChronic Diseases by Selected Geographical Region, 2012-2013 Data

Figure 2-1

World Population at Risk for Serious Bacterial Infections, Secondary to Chronic Diseases by Selected Geographical Region, 2012-2013 Data

Table 2-2

World Population by Selected Geographical Region, 2010 - 2050

Figure 2-2

World Population by Selected Geographical Region, 2010–2050

Table 2-3

Estimated World Population by Age and Geographical Region, 2013

Figure 2-3

Estimated World Population by Age and Geographical Region, 2013

Table 2-4

Average Life Expectancy in Years by Country 1980 and 2012

Figure 2-4

Average Life Expectancy in Years by Country, 1980 and 2012

Figure 2-5

U.S. Hospital Admissions and Percent of Hospital-acquired Infections (HAIs)

Table 2-5

Burn Statistics

Table 2-6

U.S. Hospital Length of Stay, Average by Age Group

Table 2-7

Average International Length of Stay, by Country 2010

Figure 2-6

Number of Nursing Care Facilities (United States), 2000-2011

Table 2-9

Estimated Nursing Service Establishments and Care Centers by Country

Table 2-10

Total Healthcare Expenditures as a Percent of GDP by Country 2010 and 2012

Figure 2-7

Total Healthcare Expenditures as a Percent of GDP by Country 2010 and 2012

Table 2-11

Healthcare Spending, Obesity and Life Expectancy, 2012

Table 2-12

U.S. States ACA HAI Prevention Infrastructure Funding Awards, 2013

Table 2-12 (continued)

U.S. States ACA HAI Prevention Infrastructure Funding Awards, 2013

Table 2-12 (continued)

U.S. States ACA HAI Prevention Infrastructure Funding Awards, 2013

Table 2-13

U.S. States Hospital Acquired Infection Standardized Infection Ratio (SIR) 2010, 2011 and 2012

Table 2-14

Pennsylvania State Analysis of HAI Readmissions and Related Costs, 2010

Table 2-15

Pennsylvania State Analysis of HAIs, 2010

THREE: INFECTION PREVENTION
Table 3-1

Summary of Advantages and Disadvantages of Chemical Agents Used as Chemical Sterilants1 or as High-Level Disinfectants

Table 3-1 (continued)

Summary of Advantages and Disadvantages of Chemical Agents Used as Chemical Sterilants1 or as High-Level Disinfectants

Table 3-2

Comparison of the Characteristics of Selected Chemicals Used as High-Level Disinfectants or Chemical Sterilants

Table 3-3

Comparison of the Characteristics of Selected Hospital Disinfectants for General Disinfection of Environmental Surfaces

Table 3-4

New Developments, Healthcare Infection Prevention

Table 3-5

The World Market for Healthcare Infection Prevention(Sterilization/Disinfection Segment) 2008-2020

Figure 3-1

The World Market for Healthcare Infection Prevention(Sterilization/Disinfection Segment) 2008-2020

Figure 3-2

The World Market for Healthcare Infection Prevention(Sterilization/Disinfection Segment) Estimated Market Share by Type(Medical Disinfection, Wide-Area Room Sterilization,Medical Device Sterilization, Other), 2014

Table 3-6

The World Market for Healthcare Infection Prevention(Sterilization/Disinfection Segment) Estimated Products Sales by Primary Geographic Region 2008-2020

Figure 3-3

The World Market for Healthcare Infection Prevention(Sterilization/Disinfection Segment) Estimated Product Sales by Primary Geographic Region 2008-2020

Figure 3-4

The World Market for Healthcare Infection Prevention(Sterilization/Disinfection Segment) Estimated Market Share by Region, 2014(US, Europe, Eastern Europe, Japan, Canada, China, Mexico, Brazil,Africa, India, ROW)

Figure 3-5

The World Market for Healthcare Infection Prevention(Sterilization/Disinfection Segment) Rest of World Snapshot, Estimated 2014(US, Europe, Eastern Europe, Japan, Canada, China, Mexico, Brazil,Africa, India, ROW)

Table 3-7

The World Market for Healthcare Infection Prevention(Sterilization/Disinfection Segment) Leading Suppliers' Shares Estimates for 2014

Figure 3-6

The World Market for Healthcare Infection Prevention(Sterilization/Disinfection Segment) Leading Suppliers' Shares Estimates for 2014

FOUR: INFECTION TESTING
Table 4-1

Recent Approvals for Detecting Serious Healthcare Infections

Table 4-1 (continued)

Recent Approvals for Detecting Serious Healthcare Infections

Table 4-1 (continued)

Recent Approvals for Detecting Serious Healthcare Infections

Table 4-1 (continued)

Recent Approvals for Detecting Serious Healthcare Infections

Figure 4-1

HAI Test Approvals* in the U.S. by Year and Type, 2000-2013 (Staph/MRSA,C.diff, Others)

Table 4-2

New Developments, Healthcare Infection Testing, as of April 2014

Table 4-3

The World Market for Healthcare Infection Testing/Diagnostics 2008-2020

Figure 4-2

The World Market for Healthcare Infection Testing/Diagnostics 2008-2020

Figure 4-3

The World Market for Healthcare Infection Testing/Diagnostics Estimated Market Share by Test Indication, 2014 (C.diff, MRSA, Other)

Table 4-4

The World Market for Healthcare Infection Testing/Diagnostics Estimated Products Sales by Primary Geographic Region 2008-2020

Figure 4-4

The World Market for Healthcare Infection Testing/Diagnostics Estimated Product Sales by Primary Geographic Region 2008-2020

Figure 4-5

The World Market for Healthcare Infection Testing/Diagnostics Estimated Market Share by Region, 2014 (US, Europe, Eastern Europe, Japan, Canada, China, Mexico, Brazil, Africa, India, ROW)

Figure 4-6

The World Market for Healthcare Infection Testing/Diagnostics Rest of World Snapshot, Estimated 2014 (Eastern Europe, Japan, Canada, China, Mexico,Brazil, Africa, India, ROW)

Table 4-5

The World Market for Healthcare Infection Testing/Diagnostics Leading Suppliers' Shares Estimates for 2014

Figure 4-7

The World Market for Healthcare Infection Testing/Diagnostics Leading Suppliers' Shares Estimates for 2014

FIVE: INFECTION TREATMENT
Table 5-1

Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)

Table 5-2

Antibiotics with Difficult Penetration

Table 5-2 (continued)

Antibiotics with Difficult Penetration

Table 5-3

Annual Sales of Select Antibacterial Products 2013

Table 5-4

New Developments, Healthcare Infection Treatments, as of March 2014

Table 5-5

The World Market for Healthcare Infection Treatment 2008-2020

Figure 5-1

The World Market for Healthcare Infection Treatment 2008-2020

Table 5-6

The World Market for Healthcare Infection Treatment Estimated Products Sales by Primary Geographic Region 2008-2020

Figure 5-2

The World Market for Healthcare Infection Treatment Estimated Product Sales by Primary Geographic Region 2008-2020

Figure 5-3

The World Market for Healthcare Infection Treatment Estimated Market Share by Region, 2014 (US, Europe, Eastern Europe, Japan, Canada, China, Mexico, Brazil, Africa, India, ROW)

Figure 5-4

The World Market for Healthcare Infection Treatment Rest of World Snapshot, Estimated 2014 (US, Europe, Eastern Europe, Japan,Canada, China, Mexico, Brazil, Africa, India, ROW)

Table 5-7

The World Market for Healthcare Infection Treatment Leading Suppliers' Shares Estimates for 2014

Figure 5-5

The World Market for Healthcare Infection Treatment Leading Suppliers' Shares Estimates for 2014

SIX: MARKET OPPORTUNITIES FOR HEALTHCARE INFECTION CONTROL
Table 6-1

The World Market for Healthcare Infection Control 2008-2020

Figure 6-1

The World Market for Healthcare Infection Control 2008-2020

Figure 6-2

The World Market for Healthcare Infection Control Estimated Market Share by Segment, 2014

Table 6-2

The World Market for Healthcare Infection Control Estimated Products Sales by Primary Geographic Region 2008-2020

Figure 6-3

The World Market for Healthcare Infection Control Estimated Product Sales by Geographic Region 2008-2020

Figure 6-4

The World Market for Healthcare Infection Control Estimated Market Share by Geographic Region, 2014

Figure 6-5

The World Market for Healthcare Infection Control Estimated Market Share by Region, 2014

To order this report: Healthcare Associated Infection (HAI) Control Markets: Disinfection, Area, Sterilization, Device Sterilization, Testing-C.diff, Testing-MRSA, Treatments
http://www.reportlinker.com/p02167908/Healthcare-Associated-Infection-HAI-Control-Markets-Disinfection-Area-Sterilization-Device-Sterilization-Testing-Cdiff-Testing-MRSA-Treatments.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.